FILTER

LATEST INTERVIEWS

Petrochemicals & Chemicals
Singapore

Ganapathy Swamy

MANAGING DIRECTOR, SINGAPORE & THE HEAD OF ONSITE ACCOUNTS, LINDE ASEAN
Singapore Chemicals 2021
Linde in Singapore describes to GBR its expansion plans for SE Asia.
Mining
Peru

Benjamin Quijandria

CEO, MINING CLUSTER OF SOUTHERN PERU (CMSP)
Mining Cluster if Southern Peru (CMSP) explains how it was inspired into being by the success of the mining clusters in Chile and Australia.
Mining
Canada

Réjean Girard

PRESIDENT, IOS SERVICES GÉOSCIENTIFIQUES
IOS explains to GBR why its solutions to technical, scientific and operational problems for mines are now more important than ever.
Mining
Canada

Josée Méthot

PRESIDENT & CEO, QUÉBEC MINING ASSOCIATION (QMA)
The Québec Mineral Association discusses the outlook for the region’s mining industry.
Mining
Chile

Darrell White

EXECUTIVE GENERAL MANAGER AMERICAS, THIESS
Chile Mining 2021
Thiess is upbeat on adding more services and expanding its operations in Chile.
Mining
Chile

Marco Riveros

VICE PRESIDENT, CHILEAN COPPER COMMISSION (COCHILCO)
Chile Mining 2021
The Chilean Copper Commission (Cochilco) speaks to GBR about how it assisted Chile’s copper industry through a difficult period.
Italy
Pharma & Life Sciences

Giovanni Sala

GENERAL MANAGER, MEDAC PHARMA
Medac Pharma explains how producers of original drugs struggle to gain a fair price in Italy.
Italy
Pharma & Life Sciences

Enrique Hausermann

PRESIDENT, EGUALIA
Egualia is the Italian association for generics, biosimilars and VMAs and comments on some of the challenges that its’ members face.
Mining
South Africa
MACIG

Roger Baxter

CEO, MINERALS COUNCIL SOUTH AFRICA
The Minerals Council of South Africa explains how it is working with the government to revive the country’s mining sector.
United States
Pharma & Life Sciences

Michael Quirmbach

CEO & PRESIDENT, CORDENPHARMA
CordenPharma is enjoying great demand for its increasing array of services.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL